Thrombin generation predicts early recurrence in breast cancer patients

Cancer patients present with a hypercoagulable state often associated with poor disease prognosis.This study aims to evaluate whether thrombin generation (TG), a global coagulation test, may be a useful tool to improve the identification of patients at high risk of early disease recurrence (ie, E-DR within 2 years) after breast cancer surgery.A cohort of 522 newly diagnosed patients with surgically resected high-risk breast cancer were enrolled...